Manage Your Liver

Why do some people like me with fatty liver develop inflammation (NASH), while some do not? Is it possible to get rid of the inflammation?


There are two types of fatty liver disease, alcoholic and nonalcoholic. Usually, inflammation caused by alcoholic fatty liver disease will go away once the patient ceases alcohol intake. The situation is different for nonalcoholic fatty liver disease (NAFLD). NAFLD is characterized by the accumulation of fat in the liver, it is a spectrum of diseases that ranges from mild to severe. Although having fat in the liver is not normal, simple fatty liver generally does not cause great harm. In addition, many people with fatty liver do not have any symptoms and have normal liver function. [1] 


However, when the buildup of fat in the liver causes inflammation in liver cells, liver health may be threatened. This situation is known as nonalcoholic steatohepatitis (NASH), a more severe form of NAFLD. NASH is characterized by buildup of fat in the liver, along with inflammation and liver damage. The ALT level of NASH patients are usually more elevated than those with fatty liver.


The exact cause of NASH is not yet known. It occurs more frequently in middle-aged and overweight or obese people. The number of female with NASH is also higher than male. Many NASH patients also have certain medical conditions such as diabetes, high blood cholesterol or triglyceride and insulin resistance. But there are also some who do not have diabetes, are not obese and have normal blood lipids. [2] Thus, at the moment, it cannot be concluded that these are the factors that lead to inflammation in the liver.


Medical professionals generally advise NASH patients to reduce weight (if overweight), control their diet and increase physical exercise to treat NASH. Besides lifestyle changes, research papers on PubMed show that a compound made from natural ingredients, YHK, has positive effects on NASH patients. [3][4] It has been proven that YHK has anti-inflammatory effects and can restore normal liver function. A double-blind clinical study of the compound also indicates that the ALT levels of patients lowered to normal level within 2 weeks of using YHK. [5]

  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are common liver diseases. They occur in people who drink little or no alcohol at all and are considered to be consequences of obesity.    However, “not obese” does not equal “no NAFLD / NASH”, since NAFLD may not be linked with obesity in some cases. Fatty liver disease may also develop in non-obese people. The terms “lean NAFLD” and “lean
Hit Questions
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver

starts here.
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us